Only show
results from:

Sort results by:

Display preferences
918 results sorted by relevancy Results per page:
Bayer Schering Pharma AG Will Terminate Registration With the U.S. SEC.
PR Newswire; Jun 4, 2007; 700+ Words ...FirstCall/ -- Bayer Schering Pharma AG, Berlin, Germany...This applies to Bayer Schering Pharma...1934. Bayer Schering Pharma AG is filing Form...depositary shares of Bayer Schering Pharma...shares of Bayer ...
Focus on the Bayer Schering Pharma AG: PharmaVitae Profile.
Business Wire; May 6, 2009; 700+ Words ...research report is available in its catalogue. Bayer Schering Pharma AG: PharmaVitae Profile http://www.reportlinker.com/p0118495/Bayer-Schering-Pharma-AG-PharmaVitae-Profile.html Introduction...
Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile.
Business Wire; Jul 27, 2009; 700+ Words ...is available in its catalogue. Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile http://www.reportlinker.com/p0133014/Reportlinker-Adds-Bayer-Schering-Pharma-AG-PharmaVitae-Profile.html Introduction...
Bayer Schering Pharma AG - Financial and Strategic Analysis Review.
M2 Presswire; May 6, 2009; 700+ Words ...6 May 2009-www.companiesandmarkets.com: Bayer Schering Pharma AG - Financial and Strategic Analysis Review(C...companiesandmarkets.com adds new report: Bayer Schering Pharma AG - Financial and Strategic Analysis Review Bayer...
Bayer Schering Pharma AG - PharmaVitae Profile.
M2 Presswire; Aug 21, 2008; 582 Words ...August 2008-www.companiesandmarkets.com: Bayer Schering Pharma AG - PharmaVitae Profile(C)1994-2008 M2 COMMUNICATIONS...companiesandmarkets.com adds new report: Bayer Schering Pharma AG - PharmaVitae Profile Introduction This analysis...
Micromet Enters Into Agreement for Solid Tumor BiTE Antibody with Bayer Schering Pharma AG.
PR Newswire; Jan 12, 2009; 700+ Words ...collaboration and license agreement with Bayer Schering Pharma AG, Germany, under which Bayer Schering Pharma has the exclusive option...of the Board of Management of Bayer Schering Pharma AG responsible for Global Drug...
Dyax Corp. and Bayer Schering Pharma AG Enter Into a Collaboration Agreement for Discovery of Therapeutic Antibodies.
Business Wire; Sep 5, 2007; 700+ Words ...today that they have entered into an agreement with Bayer Schering Pharma AG for the discovery of therapeutic antibodies. Under...therapeutic antibodies for two targets provided by Bayer Schering Pharma. Furthermore, these research activities may be...
Genzyme and Bayer Schering Pharma AG, Germany to Present New Data on Alemtuzumab in Multiple Sclerosis at ECTRIMS.
PR Newswire; Oct 11, 2007; 700+ Words ...PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer Schering Pharma AG, Germany announce that important, new clinical...study is also open to enrollment. Genzyme and Bayer Schering Pharma AG, Germany are co-developing alemtuzumab in...
Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis.
PR Newswire; Sep 26, 2007; 700+ Words ...PRNewswire-FirstCall/ -- Genzyme Corporation and Bayer Schering Pharma AG, Germany today announced that the first patient...treatment of patients with B-CLL. Genzyme and Bayer Schering Pharma AG, Germany are co-developing alemtuzumab in...
Bayer Schering Pharma AG - PharmaVitae Model.
M2 Presswire; Mar 17, 2009; 435 Words ...17 March 2009-www.companiesandmarkets.com: Bayer Schering Pharma AG - PharmaVitae Model(C)1994-2009 M2 COMMUNICATIONS...companiesandmarkets.com adds new report: Bayer Schering Pharma AG - PharmaVitae Model Introduction This model contains...
GeneGo Renews Its Agreement With Bayer Schering Pharma AG for Another Three Years.
Cancer Weekly; Jan 20, 2009; 514 Words ...systems biology and pathway analysis, announced that Bayer Schering Pharma AG has renewed its MetaCore licenses for another three years. Bayer Schering Pharma has programs for cancer, cardiovascular diseases...
Bayer Schering Pharma AG-Company Report.
M2 Presswire; Jan 27, 2009; 497 Words ...January 2009-www.companiesandmarkets.com: Bayer Schering Pharma AG-Company Report(C)1994-2009 M2 COMMUNICATIONS...companiesandmarkets.com adds new report: Bayer Schering Pharma AG-Company Report Private Company Reports provide...
Bayer's Visanne submitted for EU approval.(Bayer Schering Pharma AG)(Brief article)
Pharma Marketletter; Jan 12, 2009; 700+ Words Germany's Bayer Schering Pharma AG has submitted Visanne (dienogest 2mg) for endometriosis for...aim for global leadership," said Phil Smits, head of Bayer Schering Pharma's Women's Healthcare business unit. "As endometriosis is...
Bayer Schering Pharma AG.(NEWS)
Medical Marketing & Media; Nov 1, 2008; ; 478 Words [ILLUSTRATION OMITTED] Caption: BAYER SCHERING PHARMA AG teamed up with celebuspawn Kelly Osbourne for World...awareness of the day among healthcare professionals. Bayer Schering makes YAZ, among other contraceptive brands.
Bayer pays Micromet $6M for option on Ab.(Micromet license agreement with Bayer Schering Pharma AG)(Brief article)
Pharma Marketletter; Jan 19, 2009; 666 Words ...collaboration and license agreement with Bayer Schering Pharma AG granting the German drug major...Under the terms of the deal, Bayer will pay Micromet 4.5 million...specific BiTE antibody, which Bayer may license prior to January 5...
Bayer Schering reports strong data on Levitra at EAU.(European Association of Urology)(Bayer Schering Pharma AG)(Brief article)
Pharma Marketletter; Mar 26, 2007; 682 Words Bayer Schering Pharma AG, presented new data on its erectile dysfunction drug Levitra (vardenafil) at the 22nd annual meeting of the European Association...
Strong data on Bayer's Testogel and Nebido.( Bayer Schering Pharma AG )(Brief article)(Clinical report)
Pharma Marketletter; Apr 2, 2007; 692 Words ...Urology, held in Berlin, Germany, local drug major Bayer Schering Pharma AG presented strong data on its testosterone gel, Testogel...intramuscular depot formulation of testosterone undecanoaten. Bayer noted that low testosterone levels can have a serious...
Yaz approved in the Netherlands.(Bayer Schering Pharma AG)(Brief article)
Pharma Marketletter; Jul 16, 2007; 692 Words Bayer Schering Pharma AG, a unit of German drugmaker Bayer HealthCare, says that the Dutch regulatory authorities have approved the firm's low-dose contraceptive Yaz (3mg drospirenone20mcg ethinyl estradiol). The product has been cleared...
Bayer begins European roll-out of Qlaira.(Bayer Schering Pharma AG)(Brief article)
Pharma Marketletter; May 18, 2009; 554 Words Germany-based drugmaker Bayer Schering Pharma AG 's Qlaira (estradiol valerate/dienogest) will be available in Europe from May onwards. The agent will be marketed in several...
Betaferon NAbs not key to poor clinical response.(Bayer Schering Pharma AG)(neutralizing antibodies)(Brief article)
Pharma Marketletter; Apr 16, 2007; 700+ Words Bayer Schering Pharma AG, a division of Germany's Bayer group, says that the results of a retrospective study demonstrate that the presence of neutralizing antibodies to its multiple sclerosis drug Betaferon (interferon beta-1b, sold as...
918 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives